Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018

Raghuram Selvaraju Upgraded (BHC) to Strong Buy and Increased Target to $58 on, Dec 14th, 2018

Raghuram Selvaraju of HC Wainwright & Co., Upgraded "Bausch Health Companies Inc." (BHC) to Strong Buy and Increased Target from $25 to $58 on, Dec 14th, 2018.

Raghuram has made no other calls on BHC in the last 4 months.



There are 3 other peers that have a rating on BHC. Out of the 3 peers that are also analyzing BHC, 2 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Douglas Miehm of "RBC Capital" Maintained at Hold with Increased Target to $30 on, Monday, October 8th, 2018
  • David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $19 on, Thursday, September 13th, 2018


This is the rating of the analyst that currently disagrees with Raghuram


  • David Risinger of "Morgan Stanley" Upgraded from Hold to Buy on, Monday, November 5th, 2018